GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AKRO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Akero Therapeutics Inc. stock price took a fall of -5.05% on Thursday
(Updated on Apr 18, 2024)

Hold candidate since Apr 18, 2024 PDF

The Akero Therapeutics Inc. stock price fell by -5.05% on the last day (Thursday, 18th Apr 2024) from $21.60 to $20.51. During the last trading day the stock fluctuated 5.09% from a day low at $20.42 to a day high of $21.46. The price has fallen in 6 of the last 10 days and is down by -10.71% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -46 thousand shares and in total, 734 thousand shares were bought and sold for approximately $15.06 million.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $19.90 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 8.93% during the next 3 months and, with a 90% probability hold a price between $21.68 and $35.27 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AKRO Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Akero Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $21.65 and $25.47. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 08, 2024, and so far it has fallen -34.22%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Akero Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $18.60 and $17.89. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Akero Therapeutics Inc. finds support just below today's level at $18.60. If this is broken, then the next support from accumulated volume will be at $17.89 and $17.76.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.04 between high and low, or 5.09%. For the last week, the stock has had daily average volatility of 3.82%.

Akero Therapeutics Inc. is oversold on RSI14 (17). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: $19.14 (-6.66%) (This stock has medium daily movements and this gives medium risk. Low RSI14 is 17 which reduces the risk some. There is a sell signal from a pivot top found 28 days ago.)

Trading Expectations (AKRO) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Akero Therapeutics Inc. to open at $20.80, and during the day (based on 14 day Average True Range), to move between $19.13 and $21.89, which gives a possible trading interval of +/-$1.38 (+/-6.71%) up or down from last closing price. If Akero Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 13.43% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $20.59 (0.39%) than the support at $18.60 (9.31%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Akero Therapeutics Inc. stock A Buy?

Akero Therapeutics Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.868 Hold/Accumulate Upgraded

Predicted Opening Price for Akero Therapeutics Inc. of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$20.80 ( 1.40%) $20.51

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AKRO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 21.84 6.47 %
R2 21.44 4.53 %
R1 21.19 3.33 %
Current price: 20.51
Support S1 20.40 -0.539 %
S2 20.15 -1.74 %
S3 19.76 -3.67 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 25.19 22.82 %
R2 21.75 6.05 %
R1 20.59 0.390 %
Current price 20.51
Support S1 18.60 -9.31%
S2 17.89 -12.77%
S3 17.76 -13.41%

FAQ

What is the symbol for Akero Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Akero Therapeutics Inc. is AKRO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Akero Therapeutics Inc. Stock?
Akero Therapeutics Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Akero Therapeutics Inc. Stock?
Akero Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Akero Therapeutics Inc. Stock.

What's the current price of Akero Therapeutics Inc. Stock?
As of the end of day on the 2024-04-18, the price of an Akero Therapeutics Inc. (AKRO) share was $20.51.

What is the 52-week high and low for Akero Therapeutics Inc. Stock?
The 52-week high for Akero Therapeutics Inc. Stock is $58.38 and the 52-week low is $11.25.

What is the market capitalization of Akero Therapeutics Inc. Stock?
As of the 2024-04-18, the market capitalization of Akero Therapeutics Inc. is 1.414B.

When is the next earnings date for Akero Therapeutics Inc.?
The upcoming earnings date for Akero Therapeutics Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Akero Therapeutics Inc.

Akero Therapeutics. Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. It also conducts a Phase 2a ... AKRO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT